482
Participants
Start Date
June 30, 2010
Primary Completion Date
January 31, 2013
Study Completion Date
January 31, 2013
AZD8931
Tablet, oral, bd
anastrozole
Tablet, oral, od
Placebo
Tablet, oral
Research Site, Lake Success
Research Site, Belo Horizonte
Research Site, Goiânia
Research Site, Ijuí
Research Site, Porto Alegre
Research Site, Rio de Janeiro
Research Site, São Paulo
Research Site, Vancouver
Research Site, Ottawa
Research Site, Montreal
Research Site, Brno
Research Site, Olomouc
Research Site, Prague
Research Site, Helsinki
Research Site, Tampere
Research Site, Turku
Research Site, Bangalore
Research Site, Hyderabad
Research Site, Mumbai
Research Site, Pune
Research Site, Trivandrum
Research Site, Vellore
Research Site, Niigata
Research Site, Osaka
Research Site, Ota-shi
Research Site, Sapporo
Research Site, Durango
Research Site, Juchitán
Research Site, Mérida
Research Site, Monterrey
Research Site, Callao
Research Site, Lima
Research Site, Piura
Research Site, Iloilo City
Research Site, Lipa City
Research Site, Pasay
Research Site, Quezon City
Research Site, Bialystok
Research Site, Elblag
Research Site, Krakow
Research Site, Warsaw
Research Site, Kuzmolovsky
Research Site, Moscow
Research Site, Saint Petersburg
Research Site, Durban
Research Site, Pretoria
Research Site, Seoul
Research Site, Taipei
Research Site, Bangkok
Research Site, Songkhla
Research Site, Dnipropetrovsk
Research Site, Lviv
Research Site, Birmingham
Research Site, Bournemouth
Research Site, Coventry
Research Site, Leicester
Research Site, London
Research Site, Nottingham
Research Site, Surrey
Research Site, Wythenshawe, Manchester
Lead Sponsor
AstraZeneca
INDUSTRY